Study of V1a vasopressin receptor gene single nucleotide polymorphisms in platelet vasopressin responsiveness

Journal of Clinical Laboratory Analysis

Volumn 20, Issue 3, 2006, Pages 87-92

  Hasan, Kazi N ^a   Shoji, Masaru ^a   Tsutaya, Shoji ^b   Kudo, Ryoko ^b   Matsuda, Eriko ^b   Saito, Junko ^b   Kimura, Tokihisa ^c   Yasujima, Minoru ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^c Furukawa City Hospital   (Japan)

Author keywords

Platelet aggregation heterogeneity; Receptors; SNPs; Vasopressin; Via receptor

Indexed keywords

ARGIPRESSIN; UNCLASSIFIED DRUG; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V1A RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC MARKER; GENOTYPE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADULT; ARGININE VASOPRESSIN; BLOOD PLATELETS; DRUG COMBINATIONS; GENETIC MARKERS; HUMANS; PLATELET AGGREGATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, VASOPRESSIN;

EID: 33744779920     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20106     Document Type: Article

References (24)

1. Fuster V, Badimon L, Badimon JJ, Chescbro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes, 1. N Engl J Med 1992;326:242-250.
2. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983-989.
3. Del Zoppo GJ, Hallenback JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000;98:73-81.
4. Hamet P, Skuherska R, Pang SC, Tremblay J. Abnormalities of platelet function in hypertension and diabetes. Hypertension 1985;7:11135-142.
5. Kjeldsen SE, Rostrup M, Gjesdal K, Eide I. The cpinephrine-blood platelet connection with special reference to essential hypertension. Am Heart J 1991;122:330-336.
6. Opper C, Clement C, Schwarz H, et al. Increased number of high sensitive platelets in hypercholesterolemia, cardiovascular diseases, and after incubation with cholesterol. Atherosclerosis 1995;113:211-217.
7. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998;279:1643-1650.
8. Holmscn H. Physiological functions of platelets. Ann Med 1989;21:23-30.
9. Jin Y, Dietz HC, Montgomery RA, et al. Glanzmann thrombasthenia: cooperation between sequence variants in cis during splice site selection. J Clin Invest 1996;98:1745-1754.
10. Bray PF. Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization. Thromb Haemost 1994;72:492-502.
11. Gaxiola B, Friedl W, Propping P. Epinephrine-induced platelet aggregation: a twin study. Clin Genet 1984;26:543-548.
12. Propping P, Friedl W. Genetic control of adrenergic receptors on human platelets: a twin study. Hum Genet 1983;64:105-109.
13. Propping P, Friedl W, Hebebrand J, Lentes KU. Genetic studies at the receptor level: investigations in human twins and experimental animals. Ciba Found Symp 1986;123:42-56.
14. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ. Nucleotide polymorphisms in the a.2 gene define multiple alleles that are associated with differences in platelet a.2 β density. Blood 1998;92:2382-2388.
15. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet inlegrin a2 β1 density is associated with two silent polymorphisms in the α2 gene coding sequence. Blood 1997;89:1939-1943.
16. Share L. Role of vasopressin in cardiovascular regulation. Physiol Rev 1988;68:1248-1284.
17. Lachant NA, Smith MR, Xie ZJ, Romani WR. Heterogeneity of the aggregation response of human platelets to arginine vasopressin. Am J Hematol 1995;49:56-66.
18. Thibonnier M, Graves MK, Wagner MS, et al. Study of V1-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol 2000;32:557-564.
19. Saito S, Lida A, Sekine A, et al. Catalog of 178 variations in the Japanese population among eight human genes encoding G protein-coupled receptors (GPCRs). J Hum Genet 2003;48:461-468.
20. Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab 2000;11:406-410.
21. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998;95:8070-8074.
22. Offermanns S, Toombs CF, Hu YH, Simon MI. Defective platelet activation in Gq-deficient mice. Nature 1997;389:183-186.
23. Feng D, Lindpaintner K, Larson MG, et al. Increased platelet aggregability associated with platelet GP111a P1A2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999;19:1142-1147.
24. Young LJ, Nilsen R, Waymire KG, MacGregor GR, Insel TR. Increased affiliative response to vasopressin in mice expressing the Via receptor from a monogamous vole. Nature 1999;400:766-768.